Gene · 23705
CADM1: cell adhesion molecule 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CADM1: cell adhesion molecule 1. Genes, record 23705. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/23705
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9BY67 | Cell adhesion molecule 1 | 442 | 2 | Ensembl, GeneID, HGNC |
Source UniProt
Patents74
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2025172069 A | 2025-11-20 | 571 | Q9BY67 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 12721 | Q9BY67 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 709 | Q9BY67 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 709 | Q9BY67 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 12721 | Q9BY67 | Espacenet |
| US 12247982 B2 | 2025-03-11 | 571 | Q9BY67 | Espacenet |
| JP 2024123008 A | 2024-09-10 | 5501 | Q9BY67 | Espacenet |
| JP 2023113918 A | 2023-08-16 | 571 | Q9BY67 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 13559 | Q9BY67 | Espacenet |
| US 11400116 B2 | 2022-08-02 | 3916 | Q9BY67 | Espacenet |
1 to 10 of 74
See all 74 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,894
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CADM1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 20 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 16 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 13 | 2025 |
| P30CA091842 | Cancer Center Support Grant | 9 | 2025 |
| P30DA018343 | Yale/NIDA Neuroproteomics Center | 6 | 2025 |
| P01CA100730 | Retrovirus Models of Cancer | 5 | 2025 |
| P30CA015704 | Cancer Center Support Grant | 5 | 2025 |
| P30CA016056 | Roswell Park Cancer Center Support Grant | 5 | 2025 |
| P50CA058223 | SPORE in Breast Cancer | 5 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 5 | 2025 |
1 to 10 of 1,894Source NIH's project files
See all 1,894 nih grantsPapers3,480
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Blastocystis spp. at the human-animal interface: a systematic review and meta-analysis of genetic diversity, subtype concordance, and molecular evidence. | Infect Genet Evol | 2026 | 42778077 | PubTator, text mining | PubMed |
| Exploring the remodeling of the microglial communication network and the role of CADM1 in vascular dementia based on single-nucleus transcriptomics. | Int J Neurosci | 2026 | 42765998 | PubTator, text mining | PubMed |
| The miR-21-5p-Cell Adhesion Molecule 1 Axis in Non-Small Cell Lung Cancer Progression and Prognosis. | J Vis Exp | 2026 | 42730679 | PubTator, text mining | PubMed |
| A single-point mutation in TRPA1 drives heat resilience in oviparous embryos. | Sci Adv | 2026 | 42685214 | PubTator, text mining | PubMed |
| Surface and global proteomics identify ROR2 and other proteins as potentially actionable immunotherapeutic targets in osteosarcoma. | Cell Rep | 2026 | 42647168 | PubTator, text mining | PubMed |
| Long-term remission of chronic-type adult T-cell leukemia/lymphoma associated with Graves' disease treated with methimazole. | J Clin Exp Hematop | 2026 | 42528234 | PubTator, text mining | PubMed |
| Tumorigenesis of Hepatocellular Carcinoma Related to Metabolic Disorders With a Focus on the Hippo Pathway. | Appl Immunohistochem Mol Morphol | 2026 | 42482663 | PubTator, text mining | PubMed |
| Peripheral blood CADM1 expression and multi-gene signatures in depressive disorders: a pilot case-control study from the United Arab Emirates. | Front Psychiatry | 2026 | 42459288 | PubTator, text mining | PubMed |
| Utility of Flow Cytometry for Prognostic Prediction in Adult T-Cell Leukemia/Lymphoma. | EJHaem | 2026 | 42405269 | PubTator, text mining | PubMed |
| Dysregulation of the miR-4286 in diabetic kidney disease and its role in inflammatory response. | Diabetol Metab Syndr | 2026 | 42393799 | PubTator, text mining | PubMed |
1 to 10 of 3,480
See all 3,480 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/23705
GET https://conductscience.org/api/genes/v1/23705/patents?page=2